Long-term plasma exchange for severe refractory hypertriglyceridemia: A decade of experience demonstrates safety and efficacy

Journal of Clinical Apheresis

Volumn 24, Issue 6, 2009, Pages 254-258

  Schaap Fogler, Michal ^a   Schurr, Daniel ^a   Schaap, Tova ^a   Leitersdorf, Eran ^a   Rund, Deborah ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Acute pancreatitis; Hyperlipidemia; Plasmapheresis

Indexed keywords

ACUTE PANCREATITIS; ADULT; ALLERGIC REACTION; ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOCALCEMIA; INJECTION SITE SWELLING; LONG TERM CARE; MALE; PATIENT SAFETY; PERSONAL EXPERIENCE; PLASMAPHERESIS; RECURRENT DISEASE; SYNCOPE; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE DISEASE; ADULT; CITRIC ACID; GLUCOSE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; PANCREATITIS; PLASMA EXCHANGE;

EID: 71849110881     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20224     Document Type: Article

References (26)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
2. Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) Reference Manuals and Reports [CD-ROM]. Bethesda, MD: National Center for Health Statistics; 1996.
3. Assmann G, Cullen P, Schulte H. The Münster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998;19 (Suppl A):A2-A11.
4. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-219.
5. Lithell H, Vessby B, Walldius G, Carlson LA. Hypertrigly-ceridemia - acute pancreatitis - ischemic heart disease. A case study in a pair of monozygotic twins. Acta Med Scand 1987;221:311-316.
6. Domínguez-Muñoz JE, Carballo F, García MJ, de Diego JM, Rábago L, Simón MA, de la Morena J. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset, and severity of the disease. Br J Surg 1991;78:1230-1234.
7. Fortson MR, Freedman SN, Webster PD III. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995;90:2134-2139.
8. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004;89:2601-2607.
9. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Després JP. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179-184.
10. Warth MR, Arky RA, Knopp RH. Lipid metabolism in pregnancy. II. Altered lipid composition in intermediate, very low, low and high-density lipoprotein fractions. J Clin Endocrinol Metab 1975;41:649-655.
11. Kaysen GA, de Sain-van der Velden MG. New insights into lipid metabolism in the nephrotic syndrome. Kidney Int Suppl 1999;71:S18-S21. (Pubitemid 29304805)
12. Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med 2006;3:482-489.
13. Fredrickson DS, Lees RS. A system for phenotyping hyperlipoproteinemia. Circulation 1965;31:321-327.
14. Carnovale A, Rabitti PG, Manes G, Esposito P, Pacelli L, Uomo G. Mortality in acute pancreatitis: is it an early or a late event? JOP 2005;6:438-444.
15. Larvin M, Lansdown MR, McMahon MJ, Chalmers AG, Turney JH, Brownjohn AM. Plasmapheresis: a rational treatment for fulminant acute pancreatitis? BMJ 1988;297:593-594.
16. Athyros VG, Giouleme OI, Nikolaidis NL, Vasiliadis TV, Bouloukos VI, Kontopoulos AG, Eugenidis NP. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis. J Clin Gastroenterol 2002;34:472-475. (Pubitemid 34258331)
17. Yeh JH, Chen JH, Chiu HC. Plasmapheresis for hyperlipidemic pancreatitis. J Clin Apher 2003;18:181-185.
18. Al-Humoud H, Alhumoud E, Al-Hilali N. Therapeutic plasma exchange for acute hyperlipidemic pancreatitis: a case series. Ther Apher Dial 2008;12:202-204. (Pubitemid 351743598)
19. Piolot A, Nadler F, Cavallero E, Coquard JL, Jacotot B. Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis. Pancreas 1996;13:96-99. (Pubitemid 26187776)
20. Barter PJ, Rye KA. Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? Circulation 2006;113:1553-1555.
21. Topol EJ. Intensive statin therapy - a sea change in cardiovascular prevention. N Engl J Med 2004;350:1562-1564. (Pubitemid 38477782)
22. Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson DR. Treatment of Guillain-Barré syndrome: a cost-effectiveness analysis. J Clin Apher 1999;14:107-113. (Pubitemid 29530444)
23. Fagenholz PJ, Fernández-del Castillo C, Harris NS, Pelletier AJ, Camargo CA Jr. Direct medical costs of acute pancreatitis hospitalizations in the United States. Pancreas 2007;35:302-307.
24. Nestel PJ, Huff MW, Billington T, Fidge NH. Changes in the plasma lipoprotein distribution of apolipoproteins C-II, C-III1, C-III2 and apolipoprotein B after heparin-induced lipolysis. Biochim Biophys Acta 1982;712:94-102. (Pubitemid 12045898)
25. Sutton DM, Nair RC, Rock G. Complications of plasma exchange. Transfusion 1989;29:124-127.
26. Triantafyllou NI, Grapsa EI, Kararizou E, Psimenou E, Lagguranis A, Dimopoulos A. Periodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up. Ther Apher Dial 2009;13:174-178.